Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05192590 · ClinicalTrials.gov registry record · NA
Establishing Clinical Utility Evidence for Chronic Disease Management Testing
A NA study, sponsored by Qure Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 247
- Enrollment target
NCT05192590: Completed NA study, sponsored by Qure Healthcare.
NCT05192590 is a NA study that has completed, run by Qure Healthcare. The registered enrollment target is 247 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05192590, a NA study, has completed, sponsored by Qure Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 247 participants
- Enrollment target
Study Summary
This is a national-level research study of primary care physicians. The purpose of this study is to assess the clinical evaluation and management (drug, procedures, counseling and other) of a subset of common patient care indications.
Primary Outcome
Difference-in-differences regression analysis between the control and the intervention groups' diagnosis and treatment of chronic dyspnea, as measured by the participants diagnostic and treatment CPV case domain scores. In each domain of a CPV (history, physical exam, workup, diagnosis and treatment), participants' care recommendations are evaluated against evidence-based care scoring criteria which can sum from 0 to a high potential score of up to 100 percent in each domain, where higher scores
Interventions
- OTHER Educational Materials and Chronic Disease Management Test (CDMT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 247 participants |
| Start Date | 2021-10-22 |
| Est. Completion | 2023-02-22 |
| Phase | NA |
What the finished NCT05192590 record still lists
NCT05192590 is an interventional study that assigns participants to a tested intervention. The registered 247 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 1 intervention - of which Educational Materials and Chronic Disease Management Test (CDMT) is the first listed.
NCT05192590 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05192590 about?
NCT05192590 is a clinical study titled "Establishing Clinical Utility Evidence for Chronic Disease Management Testing". This is a national-level research study of primary care physicians. The purpose of this study is to assess the clinical evaluation and management (drug, procedures, counseling and other) of a subset of common patient care indications.
What is the current status of trial NCT05192590?
This trial is currently completed. It is a NA study. The enrollment target is 247 participants. The study started on 2021-10-22. Estimated completion is 2023-02-22.
What interventions are being tested in trial NCT05192590?
The interventions under investigation include: Educational Materials and Chronic Disease Management Test (CDMT) (OTHER).
Who is sponsoring clinical trial NCT05192590?
This trial is sponsored by Qure Healthcare, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05192590's enrollment target sits among peer trials
247 436th of 2000 higher than 1,565 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04269902 · 247 participants · Phase 3
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
- NCT04989803 · 247 participants · Phase 1
Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma
- NCT05521399 · 247 participants
Heart Transplantation - Renewal
- NCT05556824 · 247 participants · Phase 2
Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI